Otero Jose Manuel: insider trades.
Otero Jose Manuel reported 4 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 2 sales ($27K), across 1 company.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 2
- Companies
- 1
- Name as filed
- Otero Jose Manuel
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Lexeo Therapeutics, Inc. (LXEO) | Officer · Chief Operating Officer | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-14 | Lexeo Therapeutics, Inc. | A | 2,110 | $2.64 | 138,288 | Form 4 |
| 2026-08-18 | Lexeo Therapeutics, Inc. | S | 1,304 | $4.96 | 136,178 | Form 4 |
| 2026-07-01 | Lexeo Therapeutics, Inc. | S | 4,666 | $4.48 | 137,482 | Form 4 |
| 2026-06-29 | Lexeo Therapeutics, Inc. | A | 12,060 | $0 | 142,148 | Form 4 |
Questions
What stock did Otero Jose Manuel buy or sell?
Otero Jose Manuel reported 4 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 2 sales ($27K), across 1 company.
Is Otero Jose Manuel the same person as other filers with this name?
This page covers SEC CIK 2024096 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/otero-jose-manuel-2024096.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.